1. PMDA: necessary package insert revisions from April 2018

   News item 05 May 2018 Pages: 1 - 1

2. US FDA report highlights ongoing drug safety initiatives

   Review 05 May 2018 Pages: 2 - 2

3. VigiBase now contains around 17 million ADR reports

   News item 05 May 2018 Pages: 3 - 3

4. WHO: testing recommended before using Dengvaxia

   News item 05 May 2018 Pages: 4 - 4

5. Women should be fully informed about risks of valproate use

   Comment 05 May 2018 Pages: 5 - 5

6. Anticholinergic drugs linked with dementia in elderly

   Clinical study 05 May 2018 Pages: 6 - 6

7. Delabelling penicillin allergy after testing is safe and cost saving

   Clinical study 05 May 2018 Pages: 7 - 7

8. Early AEs may lead to discontinuation of letrozole

   Clinical study 05 May 2018 Pages: 8 - 8

9. Haematological adverse events with valganciclovir in CMV

   Clinical study 05 May 2018 Pages: 9 - 9

10. NSAIDs in inflammatory arthritides: risk of myocardial infarction

    Clinical study 05 May 2018 Pages: 10 - 10

11. Nuisance bleeding with OACs: prognostic significance

    Clinical study 05 May 2018 Pages: 11 - 11

12. Report from the World Drug Safety Congress US

    Meeting report 05 May 2018 Pages: 12 - 12

13. Treatment for post-Lyme disease syndrome: adverse events

    Clinical study 05 May 2018 Pages: 13 - 13

14. Abiraterone acetate

    Case report 05 May 2018 Pages: 14 - 14

15. Acetazolamide/hydrochlorothiazide

    Case report 05 May 2018 Pages: 15 - 15

16. Adalimumab

    Case report 05 May 2018 Pages: 16 - 16

17. Adalimumab/etanercept/infliximab

    Case report 05 May 2018 Pages: 17 - 17

18. Adalimumab/infliximab

    Case report 05 May 2018 Pages: 18 - 18

19. Adalimumab/methotrexate

    Case report 05 May 2018 Pages: 19 - 19

20. Afatinib

    Case report 05 May 2018 Pages: 20 - 20

21. Afatinib

    Case report 05 May 2018 Pages: 21 - 21

22. Alemtuzumab

    Case report 05 May 2018 Pages: 22 - 22

23. Alendronic acid/ibandronic acid

    Case report 05 May 2018 Pages: 23 - 23

24. Alitretinoin

    Case report 05 May 2018 Pages: 24 - 24

25. Alteplase/antineoplastics

    Case report 05 May 2018 Pages: 25 - 25

26. Amiodarone

    Case report 05 May 2018 Pages: 26 - 26

27. Amiodarone

    Case report 05 May 2018 Pages: 27 - 27

28. Amoxicillin

    Case report 05 May 2018 Pages: 28 - 28

29. Amoxicillin/bromhexine/prednisone

    Case report 05 May 2018 Pages: 29 - 29

30. Anthracyclines/doxorubicin

    Case report 05 May 2018 Pages: 30 - 30

31. Antiepileptic drugs

    Case report 05 May 2018 Pages: 31 - 31

32. Antineoplastics

    Case report 05 May 2018 Pages: 32 - 32

33. Antineoplastics

    Case report 05 May 2018 Pages: 33 - 33

34. Antineoplastics

    Case report 05 May 2018 Pages: 34 - 34

35. Antineoplastics

    Case report 05 May 2018 Pages: 35 - 35

36. Antineoplastics and doxorubicin liposomal

    Case report 05 May 2018 Pages: 36 - 36

37. Antiparkinsonians

    Case report 05 May 2018 Pages: 37 - 37

38. Antiparkinsonians and nabilone

    Case report 05 May 2018 Pages: 38 - 38

39. Antipsychotics

    Case report 05 May 2018 Pages: 39 - 39

40. Antirheumatics

    Case report 05 May 2018 Pages: 40 - 40

41. Antituberculars

    Case report 05 May 2018 Pages: 41 - 41

42. Antivirals/calcineurin inhibitors

    Case report 05 May 2018 Pages: 42 - 42

43. Asparaginase/prednisolone

    Case report 05 May 2018 Pages: 43 - 43

44. Aspirin/ketorolac

    Case report 05 May 2018 Pages: 44 - 44

45. Aspirin/Warfarin

    Case report 05 May 2018 Pages: 45 - 45

46. Asunaprevir/daclatasvir

    Case report 05 May 2018 Pages: 46 - 46

47. Atezolizumab/ipilimumab/nivolumab

    Case report 05 May 2018 Pages: 47 - 47

48. Atezolizumab/ipilimumab/pembrolizumab

    Case report 05 May 2018 Pages: 48 - 48

49. Atropine overdose

    Case report 05 May 2018 Pages: 49 - 49

50. Azathioprine

    Case report 05 May 2018 Pages: 50 - 50